Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Recently Added News
Alcon Launches Unity M Ophthalmic Surgical Microscope
Alcon announced Sept. 3 the initial commercial launch of its Unity M ophthalmic surgical microscope. The company said the microscope, which has received CE marking in Europe and regulatory approval...
X-Cel and Essilor Launch Lunara Orthokeratology Lens
X-Cel Specialty Contacts and Essilor Custom Contacts announced Aug. 31 the US launch of Lunara, a new FDA-approved orthokeratology lens. Orthokeratology, or ortho-k, uses specially designed and fit...
AI Replaces Presurgical Scans in Removal of Sight-Threatening Brain Tumor
The European Medical Journal reported Aug. 28 that artificial intelligence had provided real-time guidance for removal of a vision-threatening brain tumor at University College London Hospital (UCL...
SpyGlass Celebrates Grand Opening of New Irvine, California, Headquarters
SpyGlass Pharma celebrated the grand opening of its new Irvine, California, headquarters on Aug. 27, as the company continues to expand. SpyGlass was initially founded in Irvine in 2019 by Malik Y....
Ophthalmologist Urges Early Intervention in Dry Eye Management to Avoid Surprises
Jason Bacharach, MD, of North Bay Eye Associates in northern California, has a word of advice for ophthalmologists and optometrists. Four words, actually: interventional dry eye management (IDEM). ...
Basketball Topped US Sports Eye Injuries Treated in 2025, Statistics Show
Basketball had the highest rate of sports-related eye injuries treated in the US in 2025, with 5,236 injuries, according to new statistics published Aug. 26 by Prevent Blindness. The Chicago, Illin...
US FDA Asks for Feedback on GenAI Medical Device Regulation
The US FDA took inspiration from the way human clinicians are trained in drafting a proposal for the regulation of medical devices that feature generative artificial intelligence (GenAI), and it’s ...
Kiora Licenses Retinal Candidate to Chong Kun Dang for South Korea
Kiora Pharmaceuticals announced Aug. 10 that it had granted Chong Kun Dang (CKD) Pharmaceutical Corp. development and commercialization rights in South Korea to KIO-301 for the treatment of degener...
Samsara Vision Promotes Jason Herod to President and Chief Executive Officer
Samsara Vision, of Far Hills, New Jersey, announced Sept. 1 that Jason Herod had been promoted to president and chief executive officer. Herod joined Samsara in 2021 and most recently served as chi...
Zeiss Introduces Cataract-Only Version of DORC Eva Nexus
German company Carl Zeiss Meditec introduced on Aug. 27 a dedicated cataract version of the DORC Eva Nexus surgical system. The original Eva Nexus, a dual-function cataract and vitrectomy machine, ...
US FDA Accepts NDA for Glaucoma Drop from Nicox and Kowa, Sets PDUFA Date of April 30, 2027
France’s Nicox announced Aug. 27 that the US FDA had accepted the new drug application (NDA) for NCX 470 (bimatoprost grenod; also known as K-911) and set a Prescription Drug User Fee Act (PDUFA) t...
Bausch + Lomb Advancing Dual-Action Dry Eye Drop, Ocular Surface Pain Candidate
Bausch + Lomb reported Aug. 24 that it would advance two of its topical ocular pipeline candidates based on clinical trial results. The company’s dual-action dry eye drop candidate—combining lifite...
Past News Stories
Indigo Light Prevents Myopia Completely in Animal Model, Researchers Find
Vision researchers have found that indigo light prevents myopia completely in a tree shrew model. Their findings were published Aug. 18, 2026, in Cell Reports Medicine. The study’s lead researchers...
Light-Filtering Lenses for Migraine from Avulux Gain US FDA De Novo Marketing Nod
Avulux announced Aug. 24 that its eyeglass lenses had gained US FDA de novo marketing authorization to decrease the impact of light sensitivity in patients ages 12 and older diagnosed with episodic...
Santen Launches Rhopressa Glaucoma Drops in Japan
Santen announced Aug. 17 that it had launched Rhopressa (netarsudil ophthalmic solution) 0.02%, an eye drop targeting glaucoma and ocular hypertension, in Japan. The treatment gained marketing appr...
Japan Grants Orphan Status to Alkeus’ Oral Gildeuretinol for Stargardt
Alkeus Pharmaceuticals announced Aug. 24 that Japan’s Ministry of Health, Labour, and Welfare had granted orphan drug status to gildeuretinol, its oral therapy candidate for Stargardt disease. In J...
Biosimilars, Longer-Acting Treatments Depress Exudative Retinal Pharma Revenue
Total manufacturers’ revenue from pharmaceuticals for exudative retinal diseases are on course to decline for the second year in a row—a first since the introduction of anti-VEGF therapy in 2004. M...
Q2-2026 Ophthalmic Revenue Roundup for STAAR, Lensar, Iridex, and Lenz
STAAR Surgical, of Lake Forest, California, reported Aug. 12 that its Q2-2026 net sales were $93.5 million, a 111 percent increase over $44.3 million in Q2-2025. China sales in Q2-2026 were $52.3 m...
Lupin’s Visufarma Licenses Yuvezzi Presbyopia Drops for Europe, UK
Visufarma, a subsidiary of India-based Lupin Limited, announced Aug. 20 that it had licensed exclusive rights to the presbyopia drop Yuvezzi in the European Union, the UK, Switzerland, Norway, and ...
TearCare Label Expanded to Include Improvement of Meibomian Gland Function
Sight Sciences reported Aug. 19 that the US FDA had expanded the labeling for the TearCare thermal expression device to include improvement of meibomian gland function in adult patients with evapor...
ASRS Meeting Shines Light on Ingenuity of Retina Surgeons Around the Globe
The 2026 annual meeting of the American Society of Retina Specialists (ASRS), held in mid-July at the Palais des Congrès in Montreal, Quebec, opened with a deep dive into surgery. The first day off...
Quarterly Revenue Roundup for Carl Zeiss Meditec and Santen
German company Carl Zeiss Meditec reported Aug. 6 that its ophthalmic device revenue for the three months ended June 2026 (the third quarter of its fiscal 2025/2026 year) was €437.6 million ($499.7...
EyePoint’s Duravyu Misses Primary Visual Acuity Endpoint in Phase III Wet AMD Trial
EyePoint Pharmaceuticals reported Aug. 17 that Duravyu (vorolanib intravitreal insert) missed its primary visual acuity endpoint in topline results from the Phase III LUGANO trial in wet age-relate...
Zeiss Gains US FDA 510(k) Clearance for Clinic 360 Data Management Software
Carl Zeiss Meditec announced Aug. 19 that it had gained 510(k) clearance from the US FDA for its Clinic 360 image and data management software. The clinical analytics dashboard combines diagnostic ...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.